IL4 and breast carcinoma: As well as being a risk factor for breast cancer patients, DeNardo DG found that in murine breast cancer models, IL-4 produced by tumor infiltrating CD4 + T cells stimulate M1 to M2 transition of TAMs (Tumor-associated macrophages), thus supporting lung metastasis of breast cancer cells (19).